New FDAOncology article: The Retrofit: Lessons From Sotorasib's Dosing Conundrum - via Journal of Clinical Oncology. Authors Harpreet Singh, MD PJ Vellanki Rick Pazdur. ascopubs.org/doi/10.1200/JC… #OCEProjectOptimus #OCEPublications

Without congressional action, Medicare’s #telehealth flexibilities are set to expire at the end this year. Urge your lawmakers to pass legislation extending these flexibilities. #ASCOAdvocacy Learn more: brnw.ch/21wOBc8

BMC's Cancer Center chases cancer cures & delivers more equitable futures for all patients. Our experts are changing lives by delivering cutting-edge treatments, access to clinical trials & support beyond compare. Learn more: bit.ly/3BjCFoL #RewritingHealthcare

FDA Oncology and AACR are jointly holding a workshop to discuss DPD deficiency testing, the current landscape and future directions. Hope to see many of you there on January 16, 2025 – register for in-person or virtual attendance. aacr.org/professionals/…

Five recent titles bring mystery and magic to the season, from novels of split identity to a children’s book about escaping over-protective parents. Read our full round-up: chinabooksreview.com/2024/12/17/ncb…

Nice slide for timeline of all advances in metastatic Gastric cancer till date. ASCO #GI25 @larvol OncoAlert

𝗙𝗮𝗰𝘁𝗼𝗿 𝗫𝗜 is a plasma protein and an essential component of the coagulation cascade. Factor XI plays a key role in the intrinsic pathway culminating in thrombin generation and fibrin clot formation. Elevated levels of factor XI have been associated with an increased risk

No! No! No! Let’s not undo the improvements in access to care and outcomes we’ve achieved this past decade for patients with cancer (and others)! Here’s an easy way to reach your reps via American Cancer Society Cancer Action Network: act.fightcancer.org/a/send-message…

🧊 POLAR trial out in JAMA Oncology 🧊 Hand cooling & compression reduce taxane-induced neuropathy (CIPN) in BC pts (vs controlateral control arm) 📉Cooling: 29% vs. 50% CIPN (p=0.002) 📉Compression: 24% vs. 38% CIPN (p=0.008) #bcsm OncoAlert shorturl.at/LOXXQ

Delighted to share our new study, led by @annacgeraghty and Lehi Acosta , uncovering the cellular dysregulation underpinning cognitive impairment after CAR T cell therapy and a strategy to rescue this cellular and cognitive dysfunction in mice. 1/ cell.com/cell/fulltext/…

📣 Join us Monday at 2PM at the JCO Central Lounge! We’ll be sharing insights from the JCO OP Editorial Fellowship with Dr. Raghavan and @YenongCao — from how to write strong peer reviews to navigating the publishing process. Don’t miss it! 🔗 dailynews.ascopubs.org/do/jco-central… #ASCO25 #JCO

An amazing year and more to come!

China has now surpassed all other countries in number of new oncology clinical trials launched each year, AND also number of novel active substances (NAS) for cancers launched. IQVIA iqvia.com/library/videos…